The andropause: fact or fiction? - PubMed (original) (raw)
Review
The andropause: fact or fiction?
N Burns-Cox et al. Postgrad Med J. 1997 Sep.
Abstract
The so-called andropause is an ill-defined collection of symptoms in a group of men who may have low but may also have normal androgen levels. Unlike the proven benefits of hormone replacement therapy in women, the effects of testosterone supplementation in men are equivocal. It may increase sexual interest, but rarely to a level thought adequate by the patient. It has no proven beneficial effect on erectile dysfunction and other possible beneficial effects on haemopoesis, bone metabolism, lipids and fibrinolysis have yet to be demonstrated. With the availability of the testosterone patch, sustained increases in the serum testosterone levels will be readily achieved and could theoretically significantly affect the behaviour of subclinical prostate cancer. At the present time, testosterone replacement therapy in hypogonadal men is of proven clinical benefit; this is not the case, however, for eugonadal men with symptoms attributed to the andropause. The symptoms of the andropause fatigue can readily be explained by stress and there is no scientifically valid, placebo-controlled study that shows any benefit for testosterone supplements in this not uncommon group of patients.
Similar articles
- Testosterone and andropause: the feasibility of testosterone replacement therapy in elderly men.
Lund BC, Bever-Stille KA, Perry PJ. Lund BC, et al. Pharmacotherapy. 1999 Aug;19(8):951-6. doi: 10.1592/phco.19.11.951.31574. Pharmacotherapy. 1999. PMID: 10453966 Review. - Male andropause: myth, reality, and treatment.
Wespes E, Schulman CC. Wespes E, et al. Int J Impot Res. 2002 Feb;14 Suppl 1:S93-8. doi: 10.1038/sj.ijir.3900798. Int J Impot Res. 2002. PMID: 11850741 Review. - Prostatic complications of testosterone replacement therapy.
Jackson JA, Waxman J, Spiekerman AM. Jackson JA, et al. Arch Intern Med. 1989 Oct;149(10):2365-6. Arch Intern Med. 1989. PMID: 2679476 Review. - [Testosterone substitution with special regard to prostate cancer].
Beintker M, Behre H. Beintker M, et al. Urologe A. 2008 Dec;47(12):1588-91. doi: 10.1007/s00120-008-1798-y. Urologe A. 2008. PMID: 18931991 German. - Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging.
Cavallini G, Caracciolo S, Vitali G, Modenini F, Biagiotti G. Cavallini G, et al. Urology. 2004 Apr;63(4):641-6. doi: 10.1016/j.urology.2003.11.009. Urology. 2004. PMID: 15072869 Clinical Trial.
Cited by
- Aging and sex hormones in males.
Decaroli MC, Rochira V. Decaroli MC, et al. Virulence. 2017 Jul 4;8(5):545-570. doi: 10.1080/21505594.2016.1259053. Epub 2016 Nov 10. Virulence. 2017. PMID: 27831823 Free PMC article. Review. - Knowledge and Attitude about Andropause Among General Physicians in Shiraz, Iran 2014.
Abootalebi M, Kargar M, Jahanbin I, Sharifi AA, Sharafi Z. Abootalebi M, et al. Int J Community Based Nurs Midwifery. 2016 Jan;4(1):27-35. Int J Community Based Nurs Midwifery. 2016. PMID: 26793728 Free PMC article. - Sarcopenia and Androgens: A Link between Pathology and Treatment.
Basualto-Alarcón C, Varela D, Duran J, Maass R, Estrada M. Basualto-Alarcón C, et al. Front Endocrinol (Lausanne). 2014 Dec 18;5:217. doi: 10.3389/fendo.2014.00217. eCollection 2014. Front Endocrinol (Lausanne). 2014. PMID: 25566189 Free PMC article. Review. - Can men be trusted in population-based surveys to report couples' medical care for infertility?
Belgherbi S, de La Rochebrochard E. Belgherbi S, et al. BMC Med Res Methodol. 2018 Oct 19;18(1):111. doi: 10.1186/s12874-018-0566-y. BMC Med Res Methodol. 2018. PMID: 30340531 Free PMC article.
References
- Diabetologia. 1992 Feb;35(2):173-7 - PubMed
- JAMA. 1992 Jan 15;267(3):397-9 - PubMed
- Eur J Med. 1992 Oct;1(6):329-36 - PubMed
- Ann Epidemiol. 1992 Sep;2(5):675-82 - PubMed
- Ann Med. 1993 Dec;25(6):531-4 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical